{"id":546,"date":"2021-04-13T00:31:40","date_gmt":"2021-04-12T22:31:40","guid":{"rendered":"https:\/\/www.oncotask.fr\/prise-en-charge-therapeutique-des-patients-traites-par-anticancereux-oraux-et-accompagnement-pharmaceutique-dans-le-cadre-de-lavenant-21-de-la-convention-nationale\/"},"modified":"2021-04-16T12:27:38","modified_gmt":"2021-04-16T10:27:38","slug":"therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention","status":"publish","type":"post","link":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/","title":{"rendered":"Training pharmacists in the context of addendum 21 to the national agreement"},"content":{"rendered":"<p>Therapeutic care of patients treated with oral anticancer drugs and pharmaceutical support within the framework of addendum 21 of the national convention:<\/p>\n<p>The designers and speakers are all pharmacists with expertise and field experience in the field of oncology pharmacy in hospitals and in pharmacies.<\/p>\n<p>The training scheduled over two days provides an exhaustive approach to all aspects associated with the pharmaceutical management of patients on oral cancer drugs<\/p>\n<p>Registration open!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Therapeutic care of patients treated with oral anticancer drugs and pharmaceutical support within the framework of ad","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20,18],"tags":[],"class_list":["post-546","post","type-post","status-publish","format-standard","hentry","category-training","category-events"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Training pharmacists in the context of addendum 21 to the national agreement - Oncotask<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Training pharmacists in the context of addendum 21 to the national agreement - Oncotask\" \/>\n<meta property=\"og:description\" content=\"Therapeutic care of patients treated with oral anticancer drugs and pharmaceutical support within the framework of addendum 21 of the national convention: The designers and speakers are all pharmacists with expertise and field experience in the field of oncology pharmacy in hospitals and in pharmacies. The training scheduled over two days provides an exhaustive approach [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/\" \/>\n<meta property=\"og:site_name\" content=\"Oncotask\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-12T22:31:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-16T10:27:38+00:00\" \/>\n<meta name=\"author\" content=\"sandrine\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"sandrine\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/\"},\"author\":{\"name\":\"sandrine\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#\\\/schema\\\/person\\\/8cac8cad9a877d2074ae918bd744b822\"},\"headline\":\"Training pharmacists in the context of addendum 21 to the national agreement\",\"datePublished\":\"2021-04-12T22:31:40+00:00\",\"dateModified\":\"2021-04-16T10:27:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/\"},\"wordCount\":81,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#organization\"},\"articleSection\":[\"Oncoteach training\",\"Our events\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/\",\"url\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/\",\"name\":\"Training pharmacists in the context of addendum 21 to the national agreement - Oncotask\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#website\"},\"datePublished\":\"2021-04-12T22:31:40+00:00\",\"dateModified\":\"2021-04-16T10:27:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/events\\\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.oncotask.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formations Oncoteach\",\"item\":\"https:\\\/\\\/www.oncotask.fr\\\/categories\\\/formations\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Training pharmacists in the context of addendum 21 to the national agreement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.oncotask.fr\\\/\",\"name\":\"Oncotask\",\"description\":\"Filiale commerciale de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.oncotask.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#organization\",\"name\":\"Oncotask\",\"url\":\"https:\\\/\\\/www.oncotask.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.oncotask.fr\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/cropped-favicon.png\",\"contentUrl\":\"https:\\\/\\\/www.oncotask.fr\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/cropped-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Oncotask\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.oncotask.fr\\\/#\\\/schema\\\/person\\\/8cac8cad9a877d2074ae918bd744b822\",\"name\":\"sandrine\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/607d6b2dba90ea73cf3966f02f81a236cd54825bbd72dd96380f3f2b310426f9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/607d6b2dba90ea73cf3966f02f81a236cd54825bbd72dd96380f3f2b310426f9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/607d6b2dba90ea73cf3966f02f81a236cd54825bbd72dd96380f3f2b310426f9?s=96&d=mm&r=g\",\"caption\":\"sandrine\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Training pharmacists in the context of addendum 21 to the national agreement - Oncotask","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/","og_locale":"en_US","og_type":"article","og_title":"Training pharmacists in the context of addendum 21 to the national agreement - Oncotask","og_description":"Therapeutic care of patients treated with oral anticancer drugs and pharmaceutical support within the framework of addendum 21 of the national convention: The designers and speakers are all pharmacists with expertise and field experience in the field of oncology pharmacy in hospitals and in pharmacies. The training scheduled over two days provides an exhaustive approach [&hellip;]","og_url":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/","og_site_name":"Oncotask","article_published_time":"2021-04-12T22:31:40+00:00","article_modified_time":"2021-04-16T10:27:38+00:00","author":"sandrine","twitter_card":"summary_large_image","twitter_misc":{"Written by":"sandrine","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/#article","isPartOf":{"@id":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/"},"author":{"name":"sandrine","@id":"https:\/\/www.oncotask.fr\/#\/schema\/person\/8cac8cad9a877d2074ae918bd744b822"},"headline":"Training pharmacists in the context of addendum 21 to the national agreement","datePublished":"2021-04-12T22:31:40+00:00","dateModified":"2021-04-16T10:27:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/"},"wordCount":81,"commentCount":0,"publisher":{"@id":"https:\/\/www.oncotask.fr\/#organization"},"articleSection":["Oncoteach training","Our events"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/","url":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/","name":"Training pharmacists in the context of addendum 21 to the national agreement - Oncotask","isPartOf":{"@id":"https:\/\/www.oncotask.fr\/#website"},"datePublished":"2021-04-12T22:31:40+00:00","dateModified":"2021-04-16T10:27:38+00:00","breadcrumb":{"@id":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.oncotask.fr\/en\/events\/therapeutic-care-of-patients-treated-with-oral-cancer-and-pharmaceutical-support-within-the-framework-of-amendment-21-of-the-national-convention\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.oncotask.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Formations Oncoteach","item":"https:\/\/www.oncotask.fr\/categories\/formations\/"},{"@type":"ListItem","position":3,"name":"Training pharmacists in the context of addendum 21 to the national agreement"}]},{"@type":"WebSite","@id":"https:\/\/www.oncotask.fr\/#website","url":"https:\/\/www.oncotask.fr\/","name":"Oncotask","description":"Filiale commerciale de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique","publisher":{"@id":"https:\/\/www.oncotask.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oncotask.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.oncotask.fr\/#organization","name":"Oncotask","url":"https:\/\/www.oncotask.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oncotask.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.oncotask.fr\/wp-content\/uploads\/2021\/03\/cropped-favicon.png","contentUrl":"https:\/\/www.oncotask.fr\/wp-content\/uploads\/2021\/03\/cropped-favicon.png","width":512,"height":512,"caption":"Oncotask"},"image":{"@id":"https:\/\/www.oncotask.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.oncotask.fr\/#\/schema\/person\/8cac8cad9a877d2074ae918bd744b822","name":"sandrine","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/607d6b2dba90ea73cf3966f02f81a236cd54825bbd72dd96380f3f2b310426f9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/607d6b2dba90ea73cf3966f02f81a236cd54825bbd72dd96380f3f2b310426f9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/607d6b2dba90ea73cf3966f02f81a236cd54825bbd72dd96380f3f2b310426f9?s=96&d=mm&r=g","caption":"sandrine"}}]}},"_links":{"self":[{"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/posts\/546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/comments?post=546"}],"version-history":[{"count":1,"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/posts\/546\/revisions"}],"predecessor-version":[{"id":548,"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/posts\/546\/revisions\/548"}],"wp:attachment":[{"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/media?parent=546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/categories?post=546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oncotask.fr\/en\/wp-json\/wp\/v2\/tags?post=546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}